It must be administered in a clinic under medical supervision
Regularly including these types of questions in a representative, repeat cross-sectional household survey like the Smoking and Alcohol Toolkit Study, alongside assessment of height and weight, would offer insights into how population-level use of, and demand for, GLP-1 and GLP-1/GIP medications for weight loss is evolving over time and, importantly, how it relates to peoples BMI
For more information on diabetes management and GLP-1 receptor agonists, the Diabetes Australia provides extensive resources at References Drucker, D
Master Comparison Table Comparison by Goal GHK-CU vs Other Peptides (Non-Copper) Understanding how copper peptides compare to other peptide types helps contextualize when copper specifically offers advantages
Note: if the generic medication is not available the brand version may be supplied
These interactions have not been studied